Mackay Shields LLC’s Dynavax Technologies DVAX Stock Holding History

Mackay Shields LLC’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,100	Closed	-$597K	–	1225
2018 Q1	$597K	Buy	+30,100	New	+$520K	﹤0.01%	1091

Other funds holding DVAX

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Mackay Shields LLC's DVAX Position: Q2 2018 in Review

Mackay Shields LLC sold out of Dynavax Technologies (DVAX) in Q2 2018, closing a stake of 30,100 shares — an estimated $597K sold.

Mackay Shields LLC first reported a position in DVAX in Q1 2018 and held it in 1 quarter. The position peaked at $597K in Q1 2018. 155 funds tracked by Wall St. Rank hold DVAX as of Q2 2018.

Mackay Shields LLC reported no remaining Dynavax Technologies position as of Q2 2018 after selling out during the quarter.
Mackay Shields LLC sold 30,100 Dynavax Technologies shares in Q2 2018, an estimated $597K.
Mackay Shields LLC first reported a position in Dynavax Technologies in Q1 2018 and held it in 1 quarter.
Mackay Shields LLC's Dynavax Technologies position peaked at $597K in Q1 2018.
155 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2018.

Based on Mackay Shields LLC's 13F filing for Q2 2018, filed 6 Aug 2018.